aslan pharmaceuticals press release：News & Publications
News & Publications
Readaboutourlatestproductdevelopmentsandpartnerships,industryadvancesandevents.News.11Aug2023.ASLANPharmaceuticalsReportsSecondQuarter2023 ...。其他文章還包含有：「ASLANPharmaceuticalsAnnouncesPublicationinClinical」、「ASLANPharmaceuticalsLimited」、「ASLANPharmaceuticalsLimited(ASLN)LatestPress...」、「ASLANPharmaceuticalsReportsFirstQuarter2023...」、「ASLANPharmaceuticalsReportsSecondQuart...
查看更多 離開網站
ASLAN Pharmaceuticals Announces Publication in Clinical
https://www.globenewswire.com
ASLAN Pharmaceuticals Announces Publication in Clinical Immunology Highlighting Eblasakimab's Unique Mechanism of Action in the Treatment of ...
ASLAN Pharmaceuticals Limited
https://www.globenewswire.com
ASLAN Pharmaceuticals to Host Webcast on July 6, 2023, to Discuss Phase 2b Topline Data From TREK-AD Trial Evaluating Eblasakimab in Atopic Dermatitis.
ASLAN Pharmaceuticals Limited (ASLN) Latest Press ...
https://finance.yahoo.com
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update · Eblasakimab Monthly Dosing Shows Potential for Best-In-Class ...
ASLAN Pharmaceuticals Reports First Quarter 2023 ...
https://aslanpharma.com
... the first quarter ended March 31, 2023, and provided an update on recent corporate activities. For more information, please refer to the press release.
ASLAN Pharmaceuticals Reports Second Quarter 2023 ...
https://aslanpharma.com
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update ... Please refer to the press release in full.
ASLAN Pharmaceuticals
https://ir.aslanpharma.com
ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.
PRESS RELEASE
https://aslanpharma.com
PRESS RELEASE. ASLAN PHARMACEUTICALS ... San Mateo, California, and Singapore, March 24, 2023 – ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage,.
Press Release Archives
https://aslanpharma.com
San Mateo, California, and Singapore, June 1, 2023 – ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company ...